Two new studies look at the effects of stopping the newer, stronger drug natalizumab for multiple sclerosis (MS) during pregnancy. Natalizumab is generally prescribed for people with MS who have not responded to or cannot tolerate other treatments for MS as it can have a rare but potentially fatal side effect.


Read full article on ScienceDaily Multiple Sclerosis News